MedTrace Logo

Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19

NCT04393818 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 560

Last updated 2020-09-10

No results posted yet for this study

Summary

This study aims at evaluating the effectiveness of a mobile phone based intervention to prevent and manage mental health problems in healthcare workers at the frontline against COVID-19 in Spain. The intervention will consist in psychoeducation, delivered via a mobile App. Participants will be followed up during two weeks. The primary outcome will be symptomatology of depression, anxiety or stress.

Conditions

Interventions

BEHAVIORAL

Intervention App

Participants allocated to the intervention App will receive access to a fully operational mobile phone App. The App will be used to deliver psychoeducational materials (written and audio-visual), including: emotional training (mindfulness, moral harm, skills to manage emotions), lifestyles behaviour promotion (physical activity, diet, substance abuse, sleep disorders), work environment, and social support.

Sponsors & Collaborators

  • Universidad de las Islas Baleares

    collaborator UNKNOWN

  • Hospital Miguel Servet

    collaborator OTHER

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    collaborator OTHER

  • Andalusian School of Public Health

    collaborator OTHER_GOV

  • Hospital Son Espases

    collaborator OTHER

  • Fundació d'investigació Sanitària de les Illes Balears

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-05
Primary Completion
2020-08-24
Completion
2020-08-24

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04393818 on ClinicalTrials.gov